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1078–5Objectives. The aim of this case control study was to evaluate whether periodontitis was associated with peripheral
arterial disease (PAD).
Subjects and Methods. Twenty-five patients diagnosed with aorto-iliac and/or femoro-popliteal occlusive disease and
thirty-two generally healthy control subjects were enrolled in this study. Polymerase chain reaction (PCR) was used to
identify Porphyromonas gingivalis, Treponema denticola, Actinobacillus actinomycetemcomitans, Prevotella in-
termedia, Cytomegalovirus (CMV), Chlamydia pneumoniae, and Helicobacter pylori in tissue specimens taken from
the anastomotic site of distal bypasses. Periodontal status was evaluated; serum IgG titres against the four listed bacteria
were measured.
Results. Periodontopathic bacteria were detected in 13/25 (52%) atherosclerotic specimens. CMV or C. pneumoniae was
detected in 1/25 (4%) specimens; H. pylori was not detected from any of these specimens. Fontaine grade III or IV patients
showed higher detection frequency of P. gingivalis than Fontaine grade II patients (57.1% vs 22.2%, P¼ 0.09). After ad-
justing for age, gender, diabetes and smoking, periodontitis increased 5-fold the risk of having PAD (OR 5.45). There were
preliminary indications that periodontitis was associated with increased serum IL-6 and TNF-a concentrations.
Conclusions. This study suggests that periodontitis may be associated with an increased risk of PAD. This association
could result from the increased concentration of serum inflammatory cytokines in those with periodontitis.
 2007 Published by Elsevier Ltd on behalf of European Society for Vascular Surgery.
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Peripheral arterial disease (PAD), mostly associated
with atherosclerosis, results in obstruction to blood
flow and lower extremity ischemic ulceration or gan-
grene, with amputation eventually being required in
up to 20 to 25% of these patients.1 PAD shares the
common underlying pathology of atherosclerosis
with other cardiovascular diseases including stroke.2
It has been reported PAD patients have higher circu-
lating levels of IL-6 and TNF-a.3 Elevated vascular in-
flammatory markers including IL-6 and TNF-a aresponding author. Y.-W. Chen, Periodontology, Department of
Tissue Engineering, Graduate School, Tokyo Medical and
University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8549,
address: evelyn.peri@tmd.ac.jp (Y.-W. Chen).
884/000153+ 06 $34.00/0  2007 Published by Elsevier Ltd onsuggested to be associated with the extent of
atherosclerosis in PAD patients.4
Periodontitis is a chronic inflammatory disease of
tooth-supporting tissues caused by periodontopathic
bacteria.5 Periodontitis patients are reported to have
higher serum IL-6, CRP and neutrophils in several
studies.6e8 Serum IL-6 and CRP levels also show
a positive relation to the extent of periodontitis.7 Se-
rum TNF-a and IL-1b have been reported to be signif-
icantly higher in periodontitis patients than healthy
controls.9 These results suggest that periodontitis, as
a chronic inflammatory condition, may contribute to
increased serum inflammatory cytokines.
The relationship between periodontitis and athero-
sclerosis has been assumed since the initial observa-
tions that periodontal pathogens were identified
from atheromatous plaques.10,11 Epidemiologicalbehalf of European Society for Vascular Surgery.
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titis increases the risk of stroke and coronary heart
diseases.12e16 There is far less information about any
possible association between dental diseases and
PAD. Mendes and colleagues first reported that sub-
jects with clinical significant periodontal diseases at
baseline had a 2.27 fold greater risk for developing
PAD (OR¼ 2.27, 95% CI¼ 1.32-3.9).17 Hung et al. con-
ducted a prospective cohort study (n¼ 342) and found
that periodontal diseases were associated with a rela-
tive risk of 1.41 (95% CI¼ 1.12-1.77) for developing
PAD during a 12-year follow up.18 These two epidemi-
ological studies described the possible relation be-
tween periodontitis and PAD, but still little is known
through which route periodontitis may have influence
on PAD. In our previous studies, multiple periodonto-
pathic bacteria frequently were detected from the
diseased arteries of patients with abdominal aortic
aneurysms or Buerger’s disease.19e21 Hence periodon-
titis may be associated with multiple vascular
complications.
The aim of this case control study was to evaluate
whether periodontitis is associated with PAD. In the
present study, we investigated the localization of pe-
riodontopathic bacteria in atherosclerotic specimens.
Periodontal status was evaluated; in addition, serum
IgG titres against periodontopathic bacteria and
serum inflammatory cytokines including IL-6, TNF-a
and IL-1bwere examined in PAD patients and a control
group.Subjects and Methods
Study population
Twenty-five PAD patients diagnosed with aorto-
iliac and/or femoro-popliteal occlusive disease were
recruited from the Clinic of Vascular and Applied Sur-
gery in TokyoMedical andDental University. PADwas
diagnosed based on clinical symptoms, ankle brachial
pressure index (ABI), and angiographic findings.1 The
stage of disease was described as Fontaine grade based
on clinical symptoms: 18 patients were Fontaine grade
II (intermittent claudication), 5 patients were Fontaine
grade III (rest pain), and 2 patientswere Fontaine grade
IV (ischemic ulceration and gangrene). Fontaine grade
III or IV patients (seven patients) also were diagnosed
as having critical limb ischemia. The ABI of PAD pa-
tients ranged from 0 to 0.7, mean 0.54. Fourteen
patients had supra-inguinal occlusions, 6 patients
had infra-inguinal occlusions and 5 patients had com-
bined lesions. All patients had TASC type C or type D
lesions and underwent bypass surgery (rather thanEur J Vasc Endovasc Surg Vol 35, February 2008endovascular treatment), and a tissue sample from
the anastomotic site (anterior wall) was obtained for
PCR analysis.
Thirty-two generally healthy control subjects, de-
fined as those without atherosclerosis and normal
ABI, were matched for age, gender, race and smoking
status. Information on current health status, medical
history, drug use and smoking behavior was obtained
with the use of a questionnaire during an interview.
Subjects were excluded if they had received antibi-
otics within the previous 3 months or treatment for
periodontal disease within 6 months of the study.
All subjects provided informed consent and the study
was approved by the Ethical Committee of Tokyo
Medical and Dental University.Clinical periodontal examinations
Periodontal status was evaluated using various clini-
cal parameters by a trained periodontist, who was
blinded to clinical symptoms of PAD patients. Peri-
odontal probing depth (PD) and clinical attachment
level (CAL) were recorded at 6 points of each tooth.
CAL was calculated from the sum of probing depth
and gingival recession. The definition of periodontitis
was modified from the Atherosclerosis Risk in Com-
munities (ARIC) dental examinations described by
Beck et al.22 Participants who presented with at least
one probing site with PD 4 mm or CAL 4 mm in
each quadrant were defined as periodontitis patients.
The number of residual teeth was also recorded. Peri-
odontal examinations were performed before PAD pa-
tients received surgical operations.Detection of periodontopathic bacteria, Cytomegalovirus
(CMV), Chlamydia pneumoniae and Helicobacter
pylori in arterial specimens
25 fresh and sterile atherosclerotic specimens approx-
imately 1.5 cm long were obtained during surgery and
stored immediately at -80C until use. After speci-
mens were homogenized, a High-Pure PCR Template
Preparation Kit (Roche, Mannheim, Germany) was
used to extract DNA from the homogenized tissues.
PCR (as described previously23) was used to detect
four specific periodontopathic bacteria, namely Por-
phyromonas gingivalis, Treponema denticola, Actinobacil-
lus actinomycetemcomitans and Prevotella intermedia.
Briefly, 5 ml of sample was added to 45 ml of reaction
mixture containing 5 ml 10xPCR buffer (Promega,
Madison, WI), 1.25 unit Taq DNA polymerase
(Promega), and 0.2 mM of each of the deoxyribonucle-
otides (Pharmacia LKB, Piscataway, NJ). The optimal
Table 1. Demographic data of PAD patients and control subjects
PAD patients Control subjects
Number of subject 25 32
Age (MeanSD) 67.6 10 63.1 10
Gender (Male/Female) 21/4 28/4
Heavy smokera 21 (84.0%) 27 (84.4%)
Diabetesb 9 (36%) 3 (9.4%)
Values are given as Mean  SD.
a Heavy smokers were defined as subjects who have or had a his-
tory of smoking with20 cigarettes per day, more than 20 years.
b Diabetes was defined as a history of diagnosed diabetes, use of
insulin or hypoglycemic medication, a fasting blood glucose level
higher than 7 mmol/l or a haemoglobin A1c level above 0.07.
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gingivalis and T. denticola, and 1.0 mM for A. actinomy-
cetemcomitans and P. intermedia. PCR amplification was
performed in a DNA thermal cycler (PTC-100, MJ re-
search, Boston, MA). The detection of CMV was per-
formed by artus CMV LC PCR Kit (Roche,
Hamburg, Germany); the detection of C. pneumoniae
was performed by AMS25 (CLONIT S.r.l. Milano,
Italy); and the detection of H. pylori was performed
by MPCR kit (Maxim Biotech, Inc. San Francisco,
CA, USA) according to the manufacturer’s instructions,
respectively.
Determination of Serum IgG antibody titers
Whole blood samples were taken from all study sub-
jects at the time of dental visit. Blood samples were
centrifuged at 2500 rpm for 10 min at 4C. The se-
rum was filtered and immediately stored at e80C
until analysis. Serum IgG titers against P. gingivalis,
T. denticola, A. actinomycetemcomitans and P. intermedia
were measured using a previously described ELISA
method.24
Measurement of serum inflammatory cytokines
Serum IL-6, TNF-a, and IL-1b were measured using
high-sensitivity quantitative sandwich enzyme immu-
noassay technique (QuantikineHS; R&D Systems In-
ternational, Minneapolis, USA) according to the
manufacturer’s instructions. The minimum detectable
dose was 0.016 pg/ml for IL-6, 0.06 pg/ml for TNF-a,
and 0.1 pg/ml for IL-1b.
Statistical analysis
Descriptive statistics and statistical analyses were per-
formed with a computerised statistical package
(SPSS). The Kolmogorov-Smirnov normality test and
the Levene variance homogeneity test were applied
to examine the distribution normality of the data. Sta-
tistical differences by gender, smoking status and pe-
riodontitis prevalence between the two groups were
tested by Fisher’s exact test. The detection frequency
between Fontaine grade II patients and Fontaine
grade III or IV patients was also compared by Fisher‘s
exact test. Mann-Whitney U test was applied to com-
pare the differences in age, percentages of probing
sites with PD and CAL, number of residual teeth,
and serum IgG antibody titres. In addition, Mann-
Whitney U test was used to compare the serum cyto-
kine levels in PAD patients with periodontitis and PAD
patients without periodontitis. The same comparisonwas performed in the control subjects with periodon-
titis and control subjects without periodontitis. Logis-
tic regression was applied to test the association
between periodontitis and PAD in all subjects adjust-
ing for multiple confounding factors including smok-
ing, age, gender and diabetes. Statistical significance
was set at P< 0.05.Results
Characteristics of participants
The demographics of the PAD patients and control
subjects are shown in Table 1. There were no signifi-
cant differences regarding age, gender and smoking
status.Periodontal examinations
The prevalence of periodontitis, and percentage of
probing sites with PD 4 mm and CAL 4 mm
were significantly higher in PAD patients than control
subjects (Table 2). PAD patients also had significantly
fewer residual teeth.The detection of periodontopathic bacteria, CMV,
C. pneumoniae and H. pylori in arterial specimens
The detection frequency of P. gingivalis, T. denticola, A.
actinomycetemcomitans and P. intermedia in atheroscler-
ostic specimens was 32%(8/25), 32%(8/25), 4%(1/25)
and 20%(5/25) respectively. In 12/25 (48%) cases
none of these bacteria were detected in the atheroscle-
rotic specimens. The detection frequency of CMV and
C. pneumoniae was 4% (1/25) and 4% (1/25), respec-
tively. H. pylori was not detected in any of the
specimens.
Table 3 shows the detection frequency of periodon-
topathic bacteria, C. pneumoniae and H. pylori inEur J Vasc Endovasc Surg Vol 35, February 2008
Table 2. Periodontal examinations in PAD patients and control
subjects
PAD
patients
Control
subjects
P
Periodontitis prevalence 68.0% 31.0% 0.004
Percentage of probing sites
with PD 4mm(%)
14.8% 2.6% 0.003
Percentage of probing sites
with CAL 4mm(%)
39.0% 13.4% 0.007
Number of residual teeth 13.2 24.5 <0.001
PD, probing depth; CAL, clinical attachment level.
P.g T.d A.a P.i
I
g
G
 
T
i
t
r
e
s
 
(
u
n
i
t
)
0
2
4
6
8
10
PAD
Control
** * *
Fig. 1. Serum IgG titers against P. gingivalis, T. denticola, A.
actinomycetemcomitans and P. intermedia in PAD patients
and control subjects. *P< 0.05, **P< 0.01.
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patients. The higher frequency of P. gingivalis in Fon-
taine grade III or IV patients than Fontaine grade II
patients (57.1% vs 22.2%) was not statistically signifi-
cant (P¼ 0.09, Fisher‘s exact test).
Serum IgG titers against four periodontopathic bacteria
Fig. 1 shows the results of serum IgG antibody
levels. The IgG titers against P. gingivalis, T. denticola
and P. intermedia were significantly higher in
PAD patients than control subjects. No significant
difference was observed in the IgG titers against
A. actinomycetemcomitans.
Serum inflammatory cytokine levels
In PAD patients, the presence of periodontitis was as-
sociated with a significantly increased serum IL-6 and
TNF-a concentration (meanSD, 19.60 24.42 vs
3.81 3.58, p< 0.01 and 1.41 1.03 vs 0.55 0.51
pg/ml, p< 0.01 respectively); this difference was not
observed for IL-1b concentration (mean SD,
4.22 4.05 vs 3.10 3.58 pg/ml). Control subjects
with periodontitis also had higher serum IL-6,
TNF-a and IL-1b levels but these differences were
not statistically significant (meanSD, IL-6,
0.93 0.52 vs 0.70 0.52; TNF-a, 0.91 0.62 vs
0.51 0.51; IL-1b 0.70 1.36 vs 0.35 0.59 pg/ml).
Table 3. The detection frequency of periodontopathic bacteria, C.
pnemoniae and H. pylori in Fontaine grade II patients and Fon-
taine grade III or IV patients
Fontaine grade
II patients
(Intermittent
claudication) n¼ 18
Fontaine grade
III or IV patients
(Critical limb
ischemia) n¼ 7
P. gingivalis 4 (22.2%) 4 (57.1%)
T. denticola 6 (33.3%) 2 (28.6%)
A. actino-
mycetemcomitans
0 1 (14.3%)
P. intermedia 3 (16.7%) 2 (28.6%)
C. pneumoniae 0 1 (14.3%)
H. pylori 0 0
No significant difference was observed between these two groups.
Eur J Vasc Endovasc Surg Vol 35, February 2008Association between PAD and periodontitis
Logistic regression analysis was performed in all
study subjects to examine the association between
PAD and periodontitis (Table 4). After adjusting for
smoking, age, gender and diabetes periodontitis
raised the odds ratio for having PAD to 5.45.
Discussion
This study suggests that periodontitis patients may be
associated with a 5-fold increase in risk of developing
PAD compared with periodontally healthy subjects.
These findings support the previous epidemiological
evidence of a possible etiologic relation between pe-
riodontitis and PAD.17,18 However, our study was
small and could be subject to type I errors.
Growing evidence suggests that atherosclerosis is
a chronic inflammatory disease of the arteries resulting
from endothelial injury, followed by macrophage mi-
gration and vascular smooth muscle proliferation.25e27
Infectiousmicroorganisms such as CMV,C. pneumoniae,
H. pylori aswell as periodontopathic bacteria have been
suggested to cause endothelial dysfunction and exert
inflammatory responses.28e32 In our study, the detec-
tion frequency of CMV, C. pneumoniae and H. pylori
was much lower than the detection frequency of perio-
dontopathic bacteria.
There are several explanations for the associations
between periodontitis and PAD. Locally produced
pro-inflammatory mediators, such as IL-6, TNF-
a and IL-1b, may spill into the circulation and exert
systemic or distant effects, including the recruitment
of monocytes, up-regulate endothelial adhesion
Table 4. Association of several risk factors with PAD in logistic re-
gression model. Independent variables include periodontitis,
smoking, age, gender, and diabetes
Dependent variable: PAD
Independent variables Odds Ratio (95% CI) P value
Periodontitis 5.45 (1.5718.89) 0.007
Smoking 0.75 (0.134.43) 0.754
Age 0.99 (0.941.05) 0.813
Gender 1.65 (0.1815.61) 0.661
Diabetes 0.18 (0.031.12) 0.065
95% CI: 95% confidence interval.
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lipids.33 Preliminary observations in out study sug-
gest that periodontitis might have contributed to the
increased IL-6 and TNF-a levels in PAD patients.
Loos et al. found higher serum IL-6 level in the periph-
eral blood of periodontitis patients compared with
subjects without periodontitis.7 Gorska et al. reported
that concentrations of TNF-a and IL-1b in both serum
samples and gingival tissues were significantly higher
in periodontitis patients than healthy controls.9
Periodontopathic bacteria also may directly en-
hance atherogenesis. P. gingivalis has been demon-
strated to stimulate the expression of cell adhesion
molecules such as ICAM-1, VCAM-1, P-selectin and
E-selectin in endothelial cells31 T. denticola is sug-
gested to adhere to and invade endothelial cells by se-
creting a specific protease.32 In our study, PAD
patients showed higher IgG titres against P. gingivalis
and T. denticola and these organisms could be detected
in atherosclerotic specimens to suggest that a signifi-
cant proportion of PAD patients were infected by
these two bacteria. Both atherosclerosis and periodon-
titis have been suggested to be associated with a hy-
perinflammatory monocyte state.12 Monocytes in
periodontitis patients are comprised significantly of
activated phenotypes, which produce large amounts
of IL-6.34 Therefore, there may be other common un-
derlying risk factors (including genetic factors) for
PAD and periodontitis.
Small case-control studies, as reported here, cannot
confirm causality. Periodontitis may be one of a num-
ber of inflammatory diseases associated with PAD.
Further studies are necessary to determine whether
periodontitis is a causal factor associated with PAD,
so that more aggressive periodontal interventions
are necessary.
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